Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays
A major problem for the effective diagnosis and management of prion diseases is the lack of rapid high-throughput assays to measure low levels of prions. Such measurements have typically required prolonged bioassays in animals. Highly sensitive, but generally non-quantitative, prion detection methods have been developed based on prions' ability to seed the conversion of normally soluble protease-sensitive forms of prion protein to protease-resistant and/or amyloid fibrillar forms. Here we describe an approach for estimating the relative amount of prions using a new prion seeding assay called real-time quaking induced conversion assay (RT-QuIC). The underlying reaction blends aspects of the previously described quaking-induced conversion (QuIC) and amyloid seeding assay (ASA) methods and involves prion-seeded conversion of the alpha helix-rich form of bacterially expressed recombinant PrPC to a beta sheet-rich amyloid fibrillar form. The RT-QuIC is as sensitive as the animal bioassay, but can be accomplished in 2 days or less. Analogous to end-point dilution animal bioassays, this approach involves testing of serial dilutions of samples and statistically estimating the seeding dose (SD) giving positive responses in 50% of replicate reactions (SD50). Brain tissue from 263K scrapie-affected hamsters gave SD50 values of 1011-1012/g, making the RT-QuIC similar in sensitivity to end-point dilution bioassays. Analysis of bioassay-positive nasal lavages from hamsters affected with transmissible mink encephalopathy gave SD50 values of 103.5–105.7/ml, showing that nasal cavities release substantial prion infectivity that can be rapidly detected. Cerebral spinal fluid from 263K scrapie-affected hamsters contained prion SD50 values of 102.0–102.9/ml. RT-QuIC assay also discriminated deer chronic wasting disease and sheep scrapie brain samples from normal control samples. In principle, end-point dilution quantitation can be applied to many types of prion and amyloid seeding assays. End point dilution RT-QuIC provides a sensitive, rapid, quantitative, and high throughput assay of prion seeding activity.
Vyšlo v časopise:
Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays. PLoS Pathog 6(12): e32767. doi:10.1371/journal.ppat.1001217
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001217
Souhrn
A major problem for the effective diagnosis and management of prion diseases is the lack of rapid high-throughput assays to measure low levels of prions. Such measurements have typically required prolonged bioassays in animals. Highly sensitive, but generally non-quantitative, prion detection methods have been developed based on prions' ability to seed the conversion of normally soluble protease-sensitive forms of prion protein to protease-resistant and/or amyloid fibrillar forms. Here we describe an approach for estimating the relative amount of prions using a new prion seeding assay called real-time quaking induced conversion assay (RT-QuIC). The underlying reaction blends aspects of the previously described quaking-induced conversion (QuIC) and amyloid seeding assay (ASA) methods and involves prion-seeded conversion of the alpha helix-rich form of bacterially expressed recombinant PrPC to a beta sheet-rich amyloid fibrillar form. The RT-QuIC is as sensitive as the animal bioassay, but can be accomplished in 2 days or less. Analogous to end-point dilution animal bioassays, this approach involves testing of serial dilutions of samples and statistically estimating the seeding dose (SD) giving positive responses in 50% of replicate reactions (SD50). Brain tissue from 263K scrapie-affected hamsters gave SD50 values of 1011-1012/g, making the RT-QuIC similar in sensitivity to end-point dilution bioassays. Analysis of bioassay-positive nasal lavages from hamsters affected with transmissible mink encephalopathy gave SD50 values of 103.5–105.7/ml, showing that nasal cavities release substantial prion infectivity that can be rapidly detected. Cerebral spinal fluid from 263K scrapie-affected hamsters contained prion SD50 values of 102.0–102.9/ml. RT-QuIC assay also discriminated deer chronic wasting disease and sheep scrapie brain samples from normal control samples. In principle, end-point dilution quantitation can be applied to many types of prion and amyloid seeding assays. End point dilution RT-QuIC provides a sensitive, rapid, quantitative, and high throughput assay of prion seeding activity.
Zdroje
1. BorcheltDR
ScottM
TaraboulosA
StahlN
PrusinerSB
1990
Scrapie and cellular prion proteins differ in the kinetics of synthesis and topology in cultured cells.
J Cell Biol
110
743
752
2. CaugheyB
RaymondGJ
1991
The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive.
J Biol Chem
266
18217
18223
3. CastillaJ
SaaP
HetzC
SotoC
2005
In vitro generation of infectious scrapie prions.
Cell
121
195
206
4. DeleaultNR
HarrisBT
ReesJR
SupattaponeS
2007
Formation of native prions from minimal components in vitro.
Proc Natl Acad Sci U S A
104
9741
9746
5. KimJI
CaliI
SurewiczK
KongQ
RaymondGJ
2010
Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors.
J Biol Chem (in press)
6. KociskoDA
ComeJH
PriolaSA
ChesebroB
RaymondGJ
1994
Cell-free formation of protease-resistant prion protein.
Nature
370
471
474
7. CaugheyB
BaronGS
ChesebroB
JeffreyM
2009
Getting a grip on prions: oligomers, amyloids, anchors and pathological membrane interactions.
Annu Rev Biochem
78
177
204
8. SaborioGP
PermanneB
SotoC
2001
Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.
Nature
411
810
813
9. GadjusekDC
1996
Infectious amyloids: Subacute Spongiform Encephalopathies as Transmissible Cerebral Amyloidoses.
FieldsBN
KnipeDM
HowleyPM
Field's Virology
Philadelphia
Lippincott-Raven
2851
2900
10. JarrettJT
LansburyPTJr
1993
Seeding "One-Dimensional Crystallization" of Amyloid: A Pathogenic Mechanism in Alzheimer's Disease and Scrapie?
Cell
73
1055
1058
11. HoriuchiM
PriolaSA
ChabryJ
CaugheyB
2000
Interactions between heterologous forms of prion protein: Binding, inhibition of conversion, and species barriers.
Proc Natl Acad Sci U S A
97
5836
5841
12. ManuelidisEE
GorgaczEJ
ManuelidisL
1978
Viremia in experimental Creutzfeldt-Jakob disease.
Science
200
1069
1071
13. BrownP
RohwerRG
DunstanBC
MacAuleyC
GajdusekDC
1998
The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy.
Transfusion
38
810
816
14. SaaP
CastillaJ
SotoC
2006
Presymptomatic detection of prions in blood.
Science
313
92
94
15. MathiasonCK
PowersJG
DahmesSJ
OsbornDA
MillerKV
2006
Infectious prions in the saliva and blood of deer with chronic wasting disease.
Science
314
133
136
16. TerryLA
HowellsL
HawthornJ
EdwardsJC
MooreSJ
2009
Detection of PrPsc in blood from sheep infected with the scrapie and bovine spongiform encephalopathy agents.
J Virol
83
12552
12558
17. ThorneL
TerryLA
2008
In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie.
J Gen Virol
89
3177
3184
18. LacrouxC
SimonS
BenestadSL
MailletS
MatheyJ
2008
Prions in milk from ewes incubating natural scrapie.
PLoS Pathog
4
e1000238
19. KonoldT
MooreSJ
BellworthySJ
SimmonsHA
2008
Evidence of scrapie transmission via milk.
BMC Vet Res
4
14
20. VascellariM
NonnoR
MutinelliF
BigolaroM
Di BariMA
2007
PrPSc in salivary glands of scrapie-affected sheep.
J Virol
81
4872
4876
21. MurayamaY
YoshiokaM
OkadaH
TakataM
YokoyamaT
2007
Urinary excretion and blood level of prions in scrapie-infected hamsters.
J Gen Virol
88
2890
2898
22. GregoriL
KovacsGG
AlexeevaI
BudkaH
RohwerRG
2008
Excretion of transmissible spongiform encephalopathy infectivity in urine.
Emerg Infect Dis
14
1406
1412
23. SafarJG
LessardP
TamguneyG
FreymanY
DeeringC
2008
Transmission and detection of prions in feces.
J Infect Dis
198
81
89
24. BessenRA
ShearinH
MartinkaS
BoharskiR
LoweD
2010
Prion Shedding from Olfactory Neurons into Nasal Secretions.
PLoS Pathogens
6
e1000837
25. StampJT
BrotherstonJG
ZlotnikI
MackayJM
SmithW
1959
Further studies on scrapie.
J Comp Pathol
69
268
280
26. GregoriL
McCombieN
PalmerD
BirchP
Sowemimo-CokerSO
2004
Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood.
Lancet
364
529
531
27. HunterGD
MillsonGC
ChandlerRL
1963
Observations on the comparative infectivity of cellular fractions derived from homogenates of mouse-scrapie brain.
Res Vet Sci
4
543
549
28. PrusinerSB
BoltonDC
GrothDF
BowmanKA
CochranSP
1982
Further purification and characterization of scrapie prions.
Biochemistry
21
6942
6950
29. KlohnPC
StoltzeL
FlechsigE
EnariM
WeissmannC
2003
A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions.
Proc Natl Acad Sci U S A
100
11666
11671
30. SaaP
CastillaJ
SotoC
2006
Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification.
J Biol Chem
281
35245
35252
31. AtarashiR
MooreRA
SimVL
HughsonAG
DorwardDW
2007
Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein.
Nat Methods
4
645
650
32. AtarashiR
WilhamJM
ChristensenL
HughsonAG
MooreRA
2008
Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking.
Nat Methods
5
211
212
33. OrruCD
WilhamJM
HughsonAG
RaymondLD
McNallyKL
2009
Human variant Creutzfeldt-Jakob disease and sheep scrapie PrP(res) detection using seeded conversion of recombinant prion protein.
Protein Eng Des Sel
22
515
521
34. ColbyDW
ZhangQ
WangS
GrothD
LegnameG
2007
Prion detection by an amyloid seeding assay.
Proc Natl Acad Sci U S A
104
20914
20919
35. ColbyDW
WainR
BaskakovIV
LegnameG
PalmerCG
2010
Protease-sensitive synthetic prions.
PLoS Pathog
6
e1000736
36. ChenB
MoralesR
BarriaMA
SotoC
2010
Estimating prion concentration in fluids and tissues by quantitative PMCA.
Nat Methods
7
519
520
37. GregoriL
GrayBN
RoseE
SpinnerDS
KascsakRJ
2008
A sensitive and quantitative assay for normal PrP in plasma.
J Virol Methods
149
251
259
38. SilveiraJR
RaymondGJ
HughsonAG
RaceRE
SimVL
2005
The most infectious prion protein particles.
Nature
437
257
261
39. DoughertyRM
1964
Animal virus titration techniques.
HarrisRJC
Techniques in experimental virology
New York
Academic Press, Inc
183
186
40. RaymondGJ
ChabryJ
2004
Purification of the pathological isoform of prion protein (PrPSc or PrPres) from transmissible spongiform encephalopathy-affected brain tissue.
LehmannS
GrassiJ
Techniques in Prion Research
Basel
Birkhauser Verlag
16
26
41. LeVineHIII
1999
Quantification of beta-sheet amyloid fibril structures with thioflavin T.
Methods Enzymol
309
274
284
42. ReedLJ
MuenchH
1938
A simple method of estimating fifty per cent endpoints.
Am J Hyg
27
493
497
43. PanK-M
BaldwinM
NguyenJ
GassetM
SerbanA
1993
Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion protein.
Proc Natl Acad Sci USA
90
10962
10966
44. CallahanMA
XiongL
CaugheyB
2001
Reversibility of scrapie-associated prion protein aggregation.
J Biol Chem
276
28022
28028
45. XiongLW
RaymondLD
HayesSF
RaymondGJ
CaugheyB
2001
Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein.
J Neurochem
79
669
678
46. CaugheyBW
DongA
BhatKS
ErnstD
HayesSF
1991
Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy.
Biochemistry
30
7672
7680
47. CaugheyB
1991
In vitro expression and biosynthesis of prion protein.
Curr Top Microbiol Immunol
172
93
107
48. CzubM
BraigHR
DiringerH
1988
Replication of the scrapie agent in hamsters infected intracerebrally confirms the pathogenesis of an amyloid-inducing virosis.
J Gen Virol
69
1753
1756
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 12
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
Najčítanejšie v tomto čísle
- HIV-1 Envelope Subregion Length Variation during Disease Progression
- Coming of Age—Sexual Reproduction in Species
- Evidence That Intracellular Stages of Utilize Amino Sugars as a Major Carbon Source
- HIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention